IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

North Tide Capital, LLC

Q2 2017 Holdings

Filed 2017-08-14 | 12 holdings | $449.4K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Tivity Health IncCOM88870R102$99.6K2,500,00022.2%
Select MED Hldgs Corp(SEM)COM81619Q105$76.8K5,000,00017.1%
Gilead Sciences Inc(GILD)COM375558103$70.8K1,000,00015.7%
Mylan N VSHS EURON59465109$38.8K1,000,0008.6%
Endo Intl PLCSHSG30401106$33.5K3,000,0007.5%
Supervalu IncCOM868536103$32.9K10,000,0007.3%
Mckesson Corp(MCK)COM58155Q103$24.7K150,0005.5%
Perrigo Co PLC(PRGO)SHSG97822103$22.7K300,0005.0%
Tenet Healthcare Corp(THC)COM NEW88033G407$19.3K1,000,0004.3%
Impax Laboratories IncCOM45256B101$16.1K1,000,0003.6%
Bioscrip Inc(BIOSEUR)COM09069N108$8.1K3,000,0001.8%
Vivus IncCOM928551100$6.1K5,000,0001.4%